Abstract
Migraine headache can be debilitating. If initiated early, aggressive management may prevent severe disability and failure at school. It must be noted that treatments available for use for acute migraine headache in children and adolescents are off-label. Their use is widespread, but double-blind, placebo-controlled studies are still unavailable for this age group.
MeSH terms
-
Acute Disease
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Anticonvulsants / therapeutic use
-
Child
-
Dihydroergotamine / administration & dosage
-
Dihydroergotamine / therapeutic use
-
Drug Therapy, Combination
-
Emergency Service, Hospital
-
Headache / drug therapy*
-
Hospitalization
-
Humans
-
Metoclopramide / administration & dosage
-
Serotonin Receptor Agonists / administration & dosage
-
Serotonin Receptor Agonists / therapeutic use
-
Sumatriptan / therapeutic use
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Anticonvulsants
-
Serotonin Receptor Agonists
-
Dihydroergotamine
-
Sumatriptan
-
Metoclopramide